Basic Information
| LncRNA/CircRNA Name | TRPM2-AS |
| Synonyms | NA |
| Region | GRCh38_21:44414588-44425272 |
| Ensemble | ENSG00000230061 |
| Refseq | NR_109964 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | RNA-seq, qPCR, Luciferase reporter assay, Western blot |
| Sample | BC tissues,cell line (MCF-10A) |
| Expression Pattern | up-regulated |
| Function Description | Both TRPM2-AS and PYCR1 were significantly up-regulated yet miR-140-3p was significantly down-regulated in BC tissues compared with normal adjacent tissues. |
| Pubmed ID | 30810442 |
| Year | 2019 |
| Title | Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis. |
External Links
| Links for TRPM2-AS | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |